SF3B1 and neoplasm: To examine potential links between mutations in the splicing machinery with splicing antigenicity across tumor types, we first categorized samples in TCGA based on the presence of nonsilent mutations in the splicing factor genes SF3B1 (43) and analyzed levels of splicing antigenicity (Supplementary Table S2).